Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)

Benzer Materyaller

• Post-Marketing Pharmacovigilance of Canakinumab from the FDA Adverse Event Reporting System (FAERS)
  Yazar:: Weidong Zhang, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-01-01)
• Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study
  Yazar:: Chengzhi Liu, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-12-01)
• Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
  Yazar:: Ming-Tao Wen, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-08-01)
• Pharmacovigilance study of adverse events of vedolizumab based on the FAERS database
  Yazar:: Guanghui Yuan, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-10-01)
• A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS)
  Yazar:: Xiaomei Xiong, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-04-01)